High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: The impact of involved field radiotherapy on patterns of failure and survival

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 1, 1996, Pages 3-12

  Poen, Joseph C ^a   Hoppe, Richard T ^a   Horning, Sandra J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone marrow transplantation; High dose therapy; Hodgkin's disease; Radiotherapy

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; ETOPOSIDE;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DRUG MEGADOSE; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; TREATMENT FAILURE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0029830951     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00277-5     Document Type: Article

References (33)

1. J.E. Anderson M.R. Litzow F.R. Appelbaum G. Schoch L.D. Fisher C.D. Buckner F.B. Petersen S.W. Crawford O.W. Press J.E. Sanders W.I. Bensinger P.J. Martin R. Storb K.M. Sullivan J.A. Hansen E.D. Thomas Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: The 21 year Seattle experience J. Clin. Oncol. 11 1993 2342 2350
2. J.O. Armitage P.J. Bierman J.M. Vose J.R. Anderson D.D. Weisenburger A. Kessinger E.C. Reed W.P. Vaughan P.F. Coccia D.T. Purtilo Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease Am. J. Med. 91 1991 605 611
3. D.M. Brizel E.P. Winer L.R. Prosnitz J. Scott J. Crawford J.O. Moore J.P. Gockerman Improved survival in advanced Hodgkin's disease with the use of combined modality therapy Int. J. Radiat. Oncol. Biol. Phys. 19 1990 535 542
4. P.P. Carbone H.S. Kaplan K. Mushoff D.W. Smithers M. Tubiana Report of the committee on Hodgkin's disease staging classification Cancer Res. 31 1971 1860 1861
5. A.M. Carella A.M. Congiu E. Gaozza P. Mazza P. Ricci G. Visani G. Meloni G. Cimino L. Mangoni P. Coser G.L. Cetto R. Cimino E.P. Alessandrino E. Brusamolino G. Santini S. Tura F. Mandelli V. Rizzoli C. Bernasconi A.M. Marmont High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: An Italian study group report J. Clin. Oncol. 6 1988 1411 1416
6. R. Chopra A.K. McMillan D.C. Linch S. Yuklea G. Taghipour R. Pearce K.G. Patterson A.H. Goldstone The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients Blood 81 1993 1137 1145
7. M. Crump A.M. Smith J. Brandwein F. Couture H. Sherret D.M.C. Sutton J.G. Scott J. McCrae C. Murray D. Pantalony S.B. Sutcliffe A. Keating High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease; importance of disease status at transplant J. Clin. Oncol. 11 1993 704 711
8. C.J. Fabian C.M. Mansfield S. Dahlberg S.E. Jones T.P. Miller E. Van Slyck P.N. Grozea F.S. Morrison C.A. Coltman R.I. Fisher Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease Ann. Intern. Med. 120 1994 903 912
9. E Frei III J.K. Luce J.F. Gamble C.A. Coltman J.J. Constanzi R.W. Talley R.W. Monto H.E. Wilson J.S. Hewlett F.C. Delany E.A. Gehan Combination chemotherapy in advanced Hodgkin's disease: Induction and maintenance of remission Ann. Intern. Med. 79 1973 376 382
10. E.A. Gehan A generalized Wilcoxon test for comparing arbitrarily singly censored samples Biometrika 52 1965 203 223
11. A.M. Gianni S. Siena M. Bregni F. Lombardi L. Gandola M. Di Nicola M. Magni F. Peccatori P. Valagussa G. Bonadonna High dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease: A 6-year update Ann. Oncol. 10 1993 889 891
12. J.G. Gribben D.C. Linch C.R.J. Singer A.K. McMillan M. Jarrett A.H. Goldstone Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation Blood 73 1989 340 344
13. W.G. Harker P. Kushlan S. Rosenberg Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe Ann. Intern. Med. 101 1984 440 446
14. S.J. Horning R.S. Negrin N.J. Chao G.D. Long R.T. Hoppe K.G. Blume Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma J. Clin. Oncol. 12 1994 2552 2558
15. S. Jagannath J.O. Armitage K.A. Dicke S.L. Tucker W.S. Velasquez K. Smith W.P. Vaughan A. Kessinger L.J. Horwitz F.B. Hagemeister P. McLaughlin F. Cabanillas G. Spitzer Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease J. Clin. Oncol. 7 1989 179 185
16. R.J. Jones S. Piantadosi R.B. Mann R.F. Ambinder E.J. Seifter H.M. Vriesendorp M.D. Abeloff W.H. Burns W.S. May S.D. Rowley G.B. Vogelsang J.E. Wagner J.M. Wiley J.R. Wingard A.M. Yeager R. Saral G.W. Santos High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease J. Clin. Oncol. 8 1990 527 537
17. E.L. Kaplan P. Meier Nonparametric estimation from incomplete observations J. Am. Stat. Assoc. 53 1958 457 481
18. A. Kessinger P.J. Bierman J.M. Vose J.O. Armitage High-dose cyclophosphamide, carmustine, and etoposide followed by autologous periperhal stem cell transplantation for patients with relapsed Hodgkin's disease Blood 77 1991 2322 2325
19. D.L. Longo P.L. Duffey R.C. Young S.M. Hubbard D.C. Ihde E. Glatstein J.C. Phares E.S. Jaffe W.J. Urba V.T. DeVita Jr. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: The low probablity for cure J. Clin. Oncol. 10 1992 210 218
20. R.J. Lukes J.J. Butler The pathology nomenclature of Hodgkin's disease Cancer Res. 31 1966 1063
21. A.J. Mundt G. Sibley S. Williams D. Hallahan J. Nautiyal R.R. Weichselbaum Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease Int. J. Radiat. Oncol. Biol. Phys. 33 1995 261 270
22. R.D. Pezner A. Nademanee J.C. Niland N. Vora S.J. Forman Involved field radiation therapy for Hodkin's disease autologous bone marrow transplantation regimens Radiother. Oncol. 34 1995 23 29
23. T. Philip F. Dumont D. Teillet D. Maraninchi N.C. Gorin M. Kuentz J.L. Harousseau M. Marty R. Pinkerton P. Herve High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease Br. J. Cancer 53 1986 737 742
24. G.L. Phillips S.N. Wolff R.H. Herzig H.M. Lazarus J.W. Fay H.S. Lin D.C. Shina G.P. Glasgow R.C. Griffith C.W. Lamb G.P. Herzig Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation Blood 73 1989 2086 2092
25. A.P. Rapoport J.M. Rowe P.A. Kouides R.A. Duerst C.N. Abboud J.L. Liesveld C.H. Packman M. Eberly M. Sherman M.A. Tanner L.S. Constine J.F. Di-Persio One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome J. Clin. Oncol. 11 1993 2351 2361
26. D.E. Reece M.J. Barnett J.M. Connors R.N. Fairey J.P. Greer G.P. Herzig R.H. Herzig H.G. Klingemann S.E. O'Reilly J.D. Shepherd J.J. Spinelli N.J. Voss S.N. Wolff G.L. Phillips Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease J. Clin. Oncol. 9 1991 1871 1879
27. D.E. Reece J.M. Connors J.J. Spinelli M.J. Barnett R.N. Fairey H.G. Klingemann S.H. Nantel S. O'Reilly I.D. Shepherd H.J. Sutherland N. Voss K. Chan G.L. Phillips Intensive therapy with cyclophospamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy Blood 83 1994 1193 1199
28. E. Salloum R. Doria L.R. Farber K.B. Roberts D.L. Cooper Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study Cancer J. Sci. Am. 1 1995 267 273
29. A. Santoro V. Bonfante G. Bonadonna Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease Ann. Intern. Med. 96 1982 139 143
30. S. Viviani A. Santoro E. Negretti V. Bonfante P. Valagussa G. Bonadonna Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission Ann. Oncol. 1 1990 123 127
31. J. Yahalom S.C. Gulati M. Toia P. Maslak E.G. McCarron J.P. O'Brien C.S. Portlock D.J. Straus J. Phillips Z. Fuks Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease J. Clin. Oncol. 11 1993 1062 1070
32. J. Yahalom J. Ryu D.J. Straus J.J. Gaynor J. Myers J. Caravelli B.D. Clarkson Z. Fuks Impact of adjuvant radiation on the patterns and rate of relapse in advancedstage Hodgkin's disease treated with alternating chemotherapy combinations J. Clin. Oncol. 9 1991 2193 2201
33. R.C. Young G.P. Canellos B.A. Chabner S.M. Hubbard V.T. DeVita Jr. Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy Cancer 42 1978 1001 1007